Ordeniza, Baby Boy .
HRN: 29-32-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/17/2026
07/24/2026
IV
38mg
IV
PSNB ( Thickly Msaf)
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes